Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03670537 · ClinicalTrials.gov registry record
Iron Parameters in Non-anemic First Trimester Gravidas
A clinical trial of Pregnancy and Iron Deficiency (Without Anemia), sponsored by Auerbach Hematology Oncology Associates P C.
- Completed
- Registry status
- 102
- Enrollment target
- 1
- Study location
NCT03670537: Completed study of Pregnancy and Iron Deficiency (Without Anemia), sponsored by Auerbach Hematology Oncology Associates P C.
NCT03670537 is a study of Pregnancy and Iron Deficiency (Without Anemia) that has completed, run by Auerbach Hematology Oncology Associates P C. The registered enrollment target is 102 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03670537, a study of Pregnancy and Iron Deficiency (Without Anemia), has completed, sponsored by Auerbach Hematology Oncology Associates P C.
- COMPLETED
- Registry status
- 102 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to see the percentage of non-anemic, first trimester gravidas presenting to their obstetricians, who are iron deficient.
Primary Outcome
Either low serum ferritin or low percent transferrin saturation (TSAT)
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Iron parameters
Study Locations (1)
Maryland
- Auerbach Hematology and Oncology - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2018-02-07 |
| Est. Completion | 2018-08-24 |
What the finished NCT03670537 record still lists
NCT03670537 is an observational study that tracks outcomes without assigning an intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Iron parameters is the first listed.
NCT03670537 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT03670537 about?
NCT03670537 is a clinical study titled "Iron Parameters in Non-anemic First Trimester Gravidas". The purpose of the study is to see the percentage of non-anemic, first trimester gravidas presenting to their obstetricians, who are iron deficient.
What is the current status of trial NCT03670537?
This trial is currently completed. The enrollment target is 102 participants. The study started on 2018-02-07. Estimated completion is 2018-08-24.
What conditions does trial NCT03670537 study?
This clinical trial studies the following conditions: Pregnancy, Iron Deficiency (Without Anemia).
What interventions are being tested in trial NCT03670537?
The interventions under investigation include: Iron parameters (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03670537?
This trial is sponsored by Auerbach Hematology Oncology Associates P C, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03670537 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03670537's enrollment target sits among peer trials
102 116th of 191 higher than 76 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI